Corcept Therapeutics reported $57.24M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 119.6M 23.54M
Ani Pharmaceuticals ANIP:US $ 79.53M 8.01M
Ardelyx ARDX:US $ 47.84M 4.98M
Aurora Cannabis Inc ACB:CN 119.06M 3.8M
Biomarin Pharmaceutical BMRN:US $ 490.42M 49.4M
Bristol Myers Squibb BMY:US $ 22821M 953M
Canopy Growth Corp WEED:CN C$ 212.9M 26.35M
Corcept Therapeutics CORT:US $ 57.24M 9.7M
Depomed DEPO:US $ 138.53M 3.51M
Eleven Biotherapeutics EBIO:US $ 8.47M 3.09M
Eli Lilly And LLY:US $ 13386M 1666.7M
Esperion Therapeutics ESPR:US $ 79.08M 5.73M
Johnson & Johnson JNJ:US $ 43390M 1836M
Knight Therapeutics Inc GUD:CN C$ 121.32M 16.02M
Lannett LCI:US $ 94.36M 5.1M
Lexicon Pharmaceuticals LXRX:US $ 18.9M 3.22M
Merk MRK:US $ 22316M 1556M
Nektar Therapeutics NKTR:US $ 105.28M 20.08M
Novartis NOVN:VX SF 29807M 401M
Novartis NVS:US $ 29807M 401M
Omeros OMER:US $ 35.07M 16.72M
Pacira Pharmaceuticals PCRX:US $ 305.07M 216.04M
Pfizer PFE:US $ 39268M 3403M
Supernus Pharmaceuticals SUPN:US $ 284.56M 30.82M
Tg Therapeutics TGTX:US $ 54.66M 10.73M
Ziopharm Oncology ZIOP:US $ 21.23M 5.19M